PRMT5 promotes cancer cell migration and invasion through the E2F pathway

被引:35
作者
Barczak, Wojciech [1 ]
Jin, Li [1 ]
Carr, Simon Mark [1 ]
Munro, Shonagh [2 ]
Ward, Samuel [2 ]
Kanapin, Alexander [3 ]
Samsonova, Anastasia [3 ]
La Thangue, Nicholas B. [1 ]
机构
[1] Univ Oxford, Dept Oncol, Lab Canc Biol, Old Rd,Campus Res Bldg, Oxford OX3 7DQ, England
[2] Argonaut Therapeut Ltd, Magdalen Ctr, Oxford Sci Pk, Oxford OX4 4GA, England
[3] St Petersburg State Univ, Ctr Genome Bioinformat, St Petersburg 199034, Russia
关键词
GENE-EXPRESSION; ARGININE METHYLTRANSFERASE; PRB PATHWAY; CORTACTIN; PROTEIN; METASTASIS; OVEREXPRESSION; AMPLIFICATION; CARCINOMAS; ACTIVATION;
D O I
10.1038/s41419-020-02771-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The pRb-E2F pathway is a critical point of regulation in the cell cycle and loss of control of the pathway is a hallmark of cancer. E2F1 is the major target through which pRb exerts its effects and arginine methylation by PRMT5 plays a key role in dictating E2F1 activity. Here we have explored the functional role of the PRMT5-E2F1 axis and highlight its influence on different aspects of cancer cell biology including viability, migration, invasion and adherence. Through a genome-wide expression analysis, we identified a distinct set of genes under the control of PRMT5 and E2F1, including some highly regulated genes, which influence cell migration, invasio and adherence through a PRMT5-dependent mechanism. Most significantly, a coincidence was apparent between the expression of PRMT5 and E2F1 in human tumours, and elevated levels of PRMT5 and E2F1 correlated with poor prognosis disease. Our results suggest a causal relationship between PRMT5 and E2F1 in driving the malignant phenotype and thereby highlight an important pathway for therapeutic intervention.
引用
收藏
页数:13
相关论文
共 56 条
[1]  
Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016
[2]   Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma [J].
Braun, Christian J. ;
Stanciu, Monica ;
Boutz, Paul L. ;
Patterson, Jesse C. ;
Calligaris, David ;
Higuchi, Fumi ;
Neupane, Rachit ;
Fenoglio, Silvia ;
Cahill, Daniel P. ;
Wakimoto, Hiroaki ;
Agar, Nathalie Y. R. ;
Yaffe, Michael B. ;
Sharp, Phillip A. ;
Hemann, Michael T. ;
Lees, Jacqueline A. .
CANCER CELL, 2017, 32 (04) :411-+
[3]   Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein [J].
Carr, Simon M. ;
Munro, Shonagh ;
Sagum, Cari A. ;
Fedorov, Oleg ;
Bedford, Mark T. ;
La Thangue, Nicholas B. .
CELL DEATH AND DIFFERENTIATION, 2017, 24 (12) :2139-2149
[4]  
Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]
[5]   A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression [J].
Chen, H. ;
Lorton, B. ;
Gupta, V. ;
Shechter, D. .
ONCOGENE, 2017, 36 (03) :373-386
[6]   Arginine methylation controls growth regulation by E2F-1 [J].
Cho, Er-Chieh ;
Zheng, Shunsheng ;
Munro, Shonagh ;
Liu, Geng ;
Carr, Simon M. ;
Moehlenbrink, Jutta ;
Lu, Yi-Chien ;
Stimson, Lindsay ;
Khan, Omar ;
Konietzny, Rebecca ;
McGouran, Joanna ;
Coutts, Amanda S. ;
Kessler, Benedikt ;
Kerr, David J. ;
La Thangue, Nicholas B. .
EMBO JOURNAL, 2012, 31 (07) :1785-1797
[7]   Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma [J].
Chuma, M ;
Sakamoto, M ;
Yasuda, J ;
Fujii, G ;
Nakanishi, K ;
Tsuchiya, A ;
Ohta, T ;
Asaka, M ;
Hirohashi, S .
JOURNAL OF HEPATOLOGY, 2004, 41 (04) :629-636
[8]   Actin nucleation by WH2 domains at the autophagosome [J].
Coutts, Amanda S. ;
La Thangue, Nicholas B. .
NATURE COMMUNICATIONS, 2015, 6
[9]   Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis [J].
Cromer, A ;
Carles, A ;
Millon, R ;
Ganguli, G ;
Chalmel, F ;
Lemaire, F ;
Young, J ;
Dembélé, D ;
Thibault, C ;
Muller, D ;
Poch, O ;
Abecassis, J ;
Wasylyk, B .
ONCOGENE, 2004, 23 (14) :2484-2498
[10]   E2F1 is crucial for E2F-dependent apoptosis [J].
Denchi, EL ;
Helin, K .
EMBO REPORTS, 2005, 6 (07) :661-667